Regional Expansion iNova operates in over 75 markets across Asia, Australia, New Zealand, Middle East & Africa and Europe, indicating strong multinational distribution capabilities and opportunities to upsell across existing channels or extend product lines into additional markets.

Portfolio Leverage A broad consumer health and prescription portfolio spanning throat, cough, cold & flu, skin care, sun care, pain management, wound care, weight management and natural supplements presents cross-sell opportunities to retailers and healthcare providers looking to broaden SKU assortments.

Strategic Partnerships Recent collaborations with retailers and media campaigns (Watsons Philippines, Betadine campaigns, NarasiTV docuseries) suggest a pattern of co-branding and co-marketing that can be replicated to expand distribution, drive trial, and accelerate market penetration in new regions.

Leadership Momentum Upcoming leadership transition with a new CEO appointed in September 2026 may open doors for strategic business development initiatives, partnerships, and accelerated go-to-market plans in priority regions.

Innovation in Health Product launches such as DURO-TUSS in the Philippines and the Betadine feminine care line indicate ongoing product innovation and category expansion that can be leveraged to approach distributors and retailers seeking fresh, science-backed health solutions.